6.Cardiovascular Supporting Drugs

46
EMERGENCY SUPPORTING DRUGS SMF/BAG. ANESTESIOLOGI & REANIMASI RSUD dr. MOEWARDI/FK UNS

description

C

Transcript of 6.Cardiovascular Supporting Drugs

Page 1: 6.Cardiovascular Supporting Drugs

EMERGENCY SUPPORTING

DRUGS

SMF/BAG. ANESTESIOLOGI & REANIMASIRSUD dr. MOEWARDI/FK UNS

Page 2: 6.Cardiovascular Supporting Drugs

These drugs have the advantages in increasing on cerebral and

coronary perfusion. It also usefull to control rate and rhythm of the

heart. We administer these drugs before, during and

after CPR

Page 3: 6.Cardiovascular Supporting Drugs

IMPORTANT DRUGS• BP

- Epinephrine / adrenaline- Vasopresine- Dopamine

• HR- Atropine

• Ventricular arrhythmia- Amiodarone - Procainamide- Lidocaine - MgSO4

Page 4: 6.Cardiovascular Supporting Drugs

• Supraventriculare arrhythmia

- Adenosine- Diltiazem- Amiodarone

• AMI- Morphine - Aspirine- Nitroglycerine - Fibrinolytica

• MISC- Sodium bicarbonate- Calcium chloride

Page 5: 6.Cardiovascular Supporting Drugs

DECISION TO USE AGENT

1. Understand mechanism of action

2. Know indication for use3. Know advert effect4. Know potential interactions

Page 6: 6.Cardiovascular Supporting Drugs

EPINEPHRINE/ADRENALINE

MECHANISM OF ACTION- & adrenergic stimulation- SVR, BP (S & D)- coronary and cerebral blood flow- myocardial O2 requirement- electrical & strength of myocardium- automaticity

Page 7: 6.Cardiovascular Supporting Drugs

INDICATION - All patients in cardiac arrest- Severe hypotention- Symptomatic bradycardia- Anaphylaxis

Page 8: 6.Cardiovascular Supporting Drugs

DOSAGEa. Cardiac arrest :

1 mg I.V. flush with 20 ml NS + arm

elevation for 10-20 s 2 – 2,5 x i.v. dose through ETT

b. Non cardiac arrest : 2 – 20 mc/min

PRECAUTIONS- Precipitable in alkaline solution

Page 9: 6.Cardiovascular Supporting Drugs

VASOPRESSIN

MECHANISM OF ACTION- Potent vasoconstrictor- SVR, BP (S&D)- Coronary and cerebral blood flow

INDICATION- alternative to 1st and 2nd dose of epinephrine for VF / VT (-)

Page 10: 6.Cardiovascular Supporting Drugs

DOSAGE40 I.V. Push 1x

PRE CAUTIONmay provoke cardiac ischemia

Page 11: 6.Cardiovascular Supporting Drugs

MECHANISM OF ACTION :stimulation of dopaminergie & adrenergic receptor

INDICATION- Hipotension (70 – 100 mmHg)- Second drug for hypotensive

bradycardia

DOPAMINE

Page 12: 6.Cardiovascular Supporting Drugs

DOSAGE :- 5 – 20 mc/Kg/min- titrate to response

PRECAUTIONS :- Start after volume replacement- tapper gradually- do not mix with sodium bicarbonate- monitor I.V. site

Page 13: 6.Cardiovascular Supporting Drugs

MECHANISME OF ACTION - Block parasympathetic receptor of heart - SA node automatically - AV node conduction - Not to stimulate the hear

INDICATION - Symptomatic sinus bradycardia- While waiting for pacing- Second drug in asystole / PEA- Organophosphate poisoning

ATROPINE

Page 14: 6.Cardiovascular Supporting Drugs

DOSAGE- Arrest : 1 mg i.v. 2 - 3 mg ETT- Bradycardia : 0,5 mg i.v- Max 3 mg- Extremely large doses may be need for organophospate poisoning

PRECAUTIONS- paradoxical bradycardia with < 0,5 mg- worsen myocardial ischaemia- avoid in hypothermia bradycardia- not useful in AV block of : 2nd degree type II 3rd degree

Page 15: 6.Cardiovascular Supporting Drugs

AGENT FOR CONTROL OF RATE AND RHYTHMClassification of antiarrhythm

Vw CLASS CHANNEL EFFECT EFFECT ON ACTION POTENTIAL

DRUG

1a Na channel blockersmoderate

Phase 0Na influx

ProcainamideDisopyramide

1b Na channel blockersWeak

Phase 0Na influx

lidocain

1c Na channel blockersstrong

Phase 0Na influx

PropafenonFlecainamide

II adrenergic blockers Decreased SA node automaticitySlow av node conduction

Atenolol,Propanolol,metoprolol,esmolol,labetolol

III K channel blockers Phase 3K efflux

Amiodaron,bretilium,dofetilide,ibutilide,sotaol

IV ca channel blockers Phase 4Ca influx

Diltiazem,verapamil

Page 16: 6.Cardiovascular Supporting Drugs

AMIODARONE

MECHANISME OF ACTION- block Na, K and Ca channels- and blocking properties

INDICATION- VF/ VT cardiac arrest refractory to shock + epinephrine- Recurrent life – threatening VT- Other arrhythmias- VT narrow QRS

Page 17: 6.Cardiovascular Supporting Drugs

DOSAGE- Cardiac arrest 300 mg i.v. push (in 20 ml D5) + 150 mg i.v. push in 3 – 5 min 1x

- Ventricular tachyarrhythmias 150 mg i.v. over 10 min

- Maintenance 1 mg/min i.v. for 6 hours then 0,5 mg/min i.v. for 18 hours

- Max dose 2,2 g/day

Page 18: 6.Cardiovascular Supporting Drugs

PRECAUTIONS- Multiple drugs interaction- Long half-life (up to 40 days)- Hypotention with rapid/repeated dose- Prolong QT interval

Page 19: 6.Cardiovascular Supporting Drugs

LIDOCAINE / LIGNOCAINE

• MECHANISM OF ACTION- block Na channel- ventricular ectopy- excitability in ischemic tissue

• INDICATION - alternative to amiodarone in cardiac arrest for VT/VF - stable VT with good LV

Page 20: 6.Cardiovascular Supporting Drugs

• DOSAGE

- Loading : 1 - 1,5 mg/Kg i.v. push (arrest) 0,5 – 0,75 mg/Kg i.v. push (stable VT) ETT = 2 – 4 mg/Kg

- Maintenance :

1– 4 mg/min i.v.

Page 21: 6.Cardiovascular Supporting Drugs

- Precautions Not reccomended as prophylaxis in MI Reduce dose

- Impaired liver function - Poor LV

Stop infusion if sign of toxicity occurs

Page 22: 6.Cardiovascular Supporting Drugs

PROCAINAMIDE

MECHANISME OF ACTION :- block Na channel- ventricular ectopy- conduction

INDICATION :- suppression of recurrent VT/VF- other tachy-arrhythmias

Page 23: 6.Cardiovascular Supporting Drugs

DOSAGE :Reccurrent VT/VF :- 20 mg/min- maintenance = 1 – 4 mg/min

PRECAUTIONS :- hypotension- reduce to 12 mg/min in patient with heart/renal failure - prolong QT interval- pro-arrhythmic, esp. in AMI, K, Mg

Page 24: 6.Cardiovascular Supporting Drugs

MAGNESIUM SULPHATE• Drug of choice for Torsades de

pointes

• Dosage :- 1 – 2 gr i.v. over 5 – 20 min- then infusion 0,5 – 1 gr/hr- Titrate to control Torsades

Page 25: 6.Cardiovascular Supporting Drugs

ADENOSINE/AT

P• MECHANISME OF ACTION :

- SA node and AV node- short half life < 5 s

• INDICATION :- termination of PSVT- unstable SVT during cardioversion preparation - will be difficult to indentify SVT with narrow QRS

Page 26: 6.Cardiovascular Supporting Drugs

• DOSAGE :- 6 mg adenosine/10 mg ATP push 1 – 3 s follow by 20 ml NS if no response in 1 – 2 min- 12 mg adenosine/20 mg ATP push- 3rd dose of 12 mg adenosine/20 mg ATP

• PRECAUTIONS :flushing, dyspnoe, chest pain

Page 27: 6.Cardiovascular Supporting Drugs

DILTIAZEM

• MECHANISME OF ACTION :- Ca channel blocker- automaticity- conduction

• INDICATION :- rate control for AF- terminate stable re-entry SVT if adenosine fails

Page 28: 6.Cardiovascular Supporting Drugs

• DOSAGE :- 15 – 20 mg over 2 min- repeat in 15 min at 20 - 25 mg i.v.- then 5 – 15 mg/hr- titrate of effect

»PRECAUTIONS :Not to be used in :- wide complex tachycardia of uncertain origin- drug induced tachycardia- WPW syndrome with AF

Page 29: 6.Cardiovascular Supporting Drugs

DRUGS FOR AMI

greets all MI patients

Page 30: 6.Cardiovascular Supporting Drugs

MORPHINE

• MECHANISME OF ACTION :- relieve pain and anxiety- myocardial oxygen demand- SVR- venous capacitance

• INDICATION :- chest pain- acute cardiogenic pulmonary edema

Page 31: 6.Cardiovascular Supporting Drugs

• DOSAGE :- 2 – 4 mg i.v, slowly - Goal = pain ( - )

• PRECAUTIONS :- hypotension- CNS/respiratory depression

Page 32: 6.Cardiovascular Supporting Drugs

NITROGLYCERIN

• MECHANISME OF ACTION :Vasodilatation :- pre load, after load- coronary artery vasodilatation

• INDICATION :- ischemic chest pain- ongoing or recurrent ischaemia in MI- pulmonary edema, hypertensive urgency

Page 33: 6.Cardiovascular Supporting Drugs

• DOSAGE :- i.v. = start with 10 – 20 mc/min- SL = 0,5 mg, repeat after 5 min

• PRECAUTIONS :- hypotension- headache

Page 34: 6.Cardiovascular Supporting Drugs

ASPIRIN

• MECHANISM OF ACTION :- anti platelet aggregation- blocking production of tromboxane A2- decrease mortality caused by IMA- decrease reinfark risk

• INDICATION :- all patient with ACS

Page 35: 6.Cardiovascular Supporting Drugs

• DOSAGE :- 160 – 320 mg PO- chewing

• PRECAUTIONS :- ulcus pepticum, asthma- hypersensitive

Page 36: 6.Cardiovascular Supporting Drugs

FIBRINOLYTICS

• MECHANISME OF ACTION :reperfusion of myocardium

• INDICATION :- ST elevation MI or new LBBB- < 12 hr from onset

• CHOICE :- streptokinase

Page 37: 6.Cardiovascular Supporting Drugs

• DOSAGE :streptokinase 1,5 million unit i.v. dilute in 100 cc, infused for 30 – 60 min

• PRECAUTION :- bleeding - allergy- hypotension - reperfusion arrhythmia

• CONTRA INDICATION :- history of haemorhage stroke- history of nonhaemorhage stroke in the past year- intra cranial tumor - active internal bleeding

Page 38: 6.Cardiovascular Supporting Drugs

CALCIUM CHLORIDE

• INDICATION :- Hypo Ca- Hyper K- Ca channel blocker/-blocker overdose

• DOSAGE :5 – 10 ml 10% CaCl2

Page 39: 6.Cardiovascular Supporting Drugs

SODIUM BICARBONATE

• INDICATION :- Hyper K- Tricyclic antidepressant overdose

• DOSAGE :- 1 mmol/Kg i.v. bolus- monitor BGA

• PRECAUTION :not routine for cardiac arrest

Page 40: 6.Cardiovascular Supporting Drugs

PHARMACOLOGIC ALTERATIONSIN PREGNANCY

• metabolism and volume of distribution of drug

• increased plasma volume • changes in the blood consentration• Local anesthetic drugs induce fetal

acidosis • blocker capable of causing fetal

bradycardia

Page 41: 6.Cardiovascular Supporting Drugs

• vasopressors can cause utero-placental vasoconstriction, with reduced fetal oxygenation & carbondioxide elimination

• sodium bicarbonate crosses the placental barrier

Page 42: 6.Cardiovascular Supporting Drugs
Page 43: 6.Cardiovascular Supporting Drugs

Guidelines for Resuscitation 2005

1. Main changes in adult basic life support

2. Main changes in automated external defibrillation

3. Main changes in adult advanced life support

4. Main changes in paediatric life support

Page 44: 6.Cardiovascular Supporting Drugs

• unresponsive and not breathing

normally

• place the hands on the centre

of the chest

• 1 sec rather than 2 sec

• the ratio of compressions to ventilations is 30 : 2 • 30 compressions is being

given immediately (for adult)

• start CPR (….A-B-C etc)

• Using the rib margin method is wasting time

• each rescue breath over

1 sec

• for all adult, and children

( for a lay rescuer)

• the 2 initial rescue breaths are omitted

Main changes in adult basic life support

Page 45: 6.Cardiovascular Supporting Drugs

Main changes in adult advanced life support

1. CPR before defibrilation2. Defibrilation strategy3. Fine VF4. Adrenaline ( epinephrine )

5. Anti-arrhythmic drugs6. Thrombolytic therapy for cardiac arrest7. Post resuscitation care – therapeutic hypothermia

Page 46: 6.Cardiovascular Supporting Drugs

CPR before defibrilation

• in out of hospital C A• unwitness cardiac arrest

• do not delay defibrilation

• Give CPR for 2 minutes

(30 : 2 )

• witnessed cardiac arrest